Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga I. Adaeva has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Practical and Chromatography-Free Process for Sabizabulin (VERU-111) via an Acylaminoisoxazole Intermediate

    by Olga I. Adaeva, Dmitry V. Demchuk, Victor V. Semenov

    Sabizabulin (VERU-111) is an investigational colchicine-binding site microtubule inhibitor under consideration for clinical evaluation in metastatic pancreatic cancer. We report a scalable synthesis of sabizabulin from readily available 3,4,5-trimethoxybenzoic acid. The route was developed to address limitations in step economy, operational complexity, and scalability associated with previously reported approaches. An isoxazole fragment is introduced at an early stage and serves as a masked precursor to the imidazole core, allowing assembly of the target structure without protecting groups. The key transformation involves the two-step conversion of an acylaminoisoxazole to the corresponding acylimidazole by hydrogenation followed by cyclization. The optimized process is operationally simple and does not require chromatographic purification at any stage. The synthesis was demonstrated on a multigram scale, and sabizabulin was obtained in eight steps in 31% overall yield with a final purity of 99.2% by LC–UV.

  • Scalable Synthesis of Seven-Membered 3,4-Fused Tricyclic Indole Scaffolds Enabling Conformationally Fixed Aminobenzosuberene Analogues

    by Olga I. Adaeva, Dmitry V. Demchuk, Marina N. Semenova, Victor V. Semenov

    We report an improved and scalable synthetic route to seven-membered 3,4-fused tricyclic indole scaffolds, providing practical access to the target framework with good overall efficiency and reproducibility. A key feature is Sc(OTf)3-promoted regioselective Fischer indolization of ortho-substituted phenylhydrazone 5b, which overrides the anomalous pathway observed under conventional acidic conditions. The synthetic utility of the scaffold was demonstrated through the preparation of aminobenzosuberene-inspired derivatives. Preliminary biological evaluation revealed that compound 1b exhibited antimitotic activity at 0.2 μM.

  • Open Access

    Apiol from Parsley Seeds as a Source for the Synthesis of Coenzyme Q 0 Propanoic Acid Conjugates with Amines Featuring Antioxidant Activity

    by Olga I. Adaeva, Dmitry V. Demchuk, Oksana G. Shevchenko, Marina N. Semenova, Victor V. Semenov

    Quinone-containing compounds are known for their free-radical scavenging activity and pronounced antioxidant properties. They could be promising for the alleviation of progressive neuronal damage in neurodegenerative diseases, caused in particular by oxidative stress. In this study, coenzyme Q0 derivatives featuring the fragment of natural quinone propanoic acid conjugated with dopamine, 5-methoxytryptamine, β-alanine, and γ-aminobutyric acid were synthesized. Apiol, the main metabolite of parsley seed extract, was used as a starting material. The aim of this study was to explore antioxidant activity of the targeted compounds in vitro using several assays, including determination of free radical scavenging capacity, inhibition of lipid peroxidation in mouse brain homogenate, and evaluation of toxicity and membrane-protective effects in mouse red blood cells (RBCs). All conjugates of the quinone propanoic acid fragment demonstrated significant antioxidant activity. The free radical scavenging capacity of the compounds in DPPH and ABTS tests was associated with the presence and amount of unsubstituted OH groups in the aromatic ring. The dopamine derivative was identified as the most potent inhibitor of both oxidative mouse RBC hemolysis and intracellular generation of reactive oxygen species. The 5-methoxytryptamine quinone derivative considerably suppressed Fe2+/ascorbate-initiated lipid peroxidation in the mouse brain homogenate. All compounds showed no toxicity on a sea urchin embryo model and could be considered potential neuroprotective agents due to the antioxidant properties of the quinone fragment and facile cleavage of the labile amide bond, thereby providing the targeted delivery of biogenic amines into the desired location.

  • Open Access

    MQPD: An Antioxidant Quinone–Dopamine Hybrid Which Induces Sustained Brain Dopamine Elevation

    by Olga Kulikova, Olga Adaeva, Yulia Timoshina, Denis Abaimov, Olga Muzychuk, Maxim Nesterov, Alexander Lopachev, Rogneda Kazanskaya, Dmitry Demchuk, Victor Semenov, et al.

    Parkinson’s disease (PD) therapy is challenged by the multifactorial nature of neurodegeneration, necessitating an approach combining dopamine replenishment and combating oxidative stress. This study characterizes the neuroprotective potential of MQPD, a novel hybrid molecule containing dopamine with a quinone fragment structurally analogous to coenzyme Q. We evaluated MQPD’s antioxidant capacity in vitro using DPPH radical scavenging and lipid peroxidation assays, its neuroprotective efficacy against mitochondrial toxins (rotenone, paraquat) in neuronal cultures, and its ability to modulate striatal dopamine levels in mice. MQPD demonstrated significant antioxidant activity, reduced reactive oxygen species, and was more effective than dopamine or L-DOPA in mitigating toxin-induced cell death. While MQPD itself showed low brain bioavailability, its administration resulted in a sustained increase in striatal dopamine levels for up to four days. The results indicate that MQPD is a potent neuroprotective agent whose effects are likely mediated by direct antioxidant activity and a long-acting mechanism that stabilizes tissue dopamine levels, offering a promising alternative to current therapies for PD.


  • Open Access

    6,7-Dihydroxy-5,8-dimethoxy-2H-chromen-2-one

    by Olga I. Adaeva, Dmitry V. Demchuk, Victor V. Semenov

    This article presents a novel approach for synthesizing a new 5,8-dimethoxy derivative of esculetin via the selective cleavage of the methylene bridge in sabandin—naturally occurring and easily synthetically accessible methoxylated coumarin. A high selectivity is achieved by using acetoxylation of methylenedioxy group with lead tetraacetate. Natural coumarin sabandin as a starting compound was prepared in a few simple steps from 5-allyl-4,7-dimethoxybenzo[d][1,3]dioxole (apiol), which is readily available from parsley and dill seed extracts. The developed method enables an efficient and straightforward synthesis of a new derivative of esculetin with potential medicinal and therapeutic applications.